Technique of intravitreal drug injection for therapy of vitreoretinal diseases;Técnica para injeção intravítrea de drogas no tratamento de doenças vítreorretinianas

Arquivos Brasileiros de Oftalmologia

Volumn 71, Issue 6, 2008, Pages 902-907

  Rodrigues, Eduardo Buchele ^a   Maia, Mauricio ^a   Penha, Fernando Marcondes ^a   Dib, Eduardo ^a   Bordon, Arnaldo Furman ^a   Magalhães Jr , Octaviano ^a   Farah, Michel Eid ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Age effect; Blindness; Intravitreal injection; Macular degeneration; Retina; Vascular endothelial growth factor

Indexed keywords

TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; ENDOPHTHALMITIS; EYE DISEASE; HUMAN; INJECTION; METHODOLOGY; NEEDLE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETINA DETACHMENT; RETINA DISEASE; VITREOUS BODY;

ANTI-INFECTIVE AGENTS, LOCAL; ENDOPHTHALMITIS; EYE DISEASES; HUMANS; INJECTIONS; NEEDLES; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETINAL DETACHMENT; RETINAL DISEASES; VITREOUS BODY;

EID: 67649890023     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492008000600028     Document Type: Article

References (31)

1. Rodrigues EB, Rossi EM, Grumann Júnior A, Meyer CH, Ho AC. Tratamento da forma neovascular de degeneração macular relacionada à idade com drogas antiangiogênicas. Arq Bras Oftalmol. 2006;69(5):756-65.
2. Oliveira Neto H, Bordon AF, Farah ME, Breuer M, Uno F. Estudo e classificação das membranas neovasculares subretinianas na degeneração macular relacionada à idade pela angiografia digital com indocianina verde. Arq Bras Oftalmol. 1998;61(3):312-22.
3. Farah ME, Oshima A, Costa RA, Sallum JF. Degeneração macular relacionada à idade: modalidades terapêuticas. Arq Bras Oftalmol. 2001;64(6):583-8.
4. Kurz D, Ciulla TA. Novel approaches for retinal drug delivery. Ophthalmol Clin North Am. 2002;15(3):405-10. Review.
5. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr, et al. Evolving guidelines for intravitreous injections. Retina. 2004; 24(Suppl 5):S3-19. Review.
6. Jaissle GB, Szurman P, Bartz-Schmidt KU, German Retina Society; German Society of Ophthalmology; German Professional Association of Ophthalmologists. [Recommendation for the implementation of intravitreal injections statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. Klin Monatsbl Augenheilkd. 2005;222(5):390-5. German.
7. Ta CN. Minimizing the risk of endophthalmitis following intravitreous injections. Retina. 2004;24(5):699-705.
8. Bucher RS, Hall E, Reed DM, Richards JE, Johnson MW, Zacks DN. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment. Arch Ophthalmol. 2005; 123(5):649-53.
9. Bucher RS, Johnson MW. Microbiologic studies of multiple-dose containers of triamcinolone acetonide and lidocaine hydrochloride. Retina. 2005;25(3):269-71.
10. Bylsma G, Guymer R, Qureshi S, Gin T, Allen P, Madhok P, et al. Intravitreous injections. Clin Experiment Ophthalmol. 2006;34(4):388-90.
11. Scott IU, Flynn HW Jr. The role of topical antibiotic prophylaxis for intravitreal injections. Arch Ophthalmol. 2007;125(7):974-6.
12. Jaissle GB, Bartz-Schmidt KU. [Intravitreal injections high standard of the procedure necessary]. Klin Monatsbl Augenheilkd. 2005;222(5):389. German.
13. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: A comprehensive review. Retina. 2004;24(5):676-98.
14. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: An evidence-based update. Ophthalmology. 2002;109(1):13-24. Comment in: Ophthalmology. 2003;110(8):1667; author reply 1667-8. Ophthalmology. 2003;110(8):1668; author reply 1669.
15. Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102(5):728-9.
16. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769-75.
17. Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis. 2004;38(4):542-6.
18. Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis. Curr Opin Ophthalmol. 2002;13(1):14-8.
19. Perry LD, Skaggs C. Preoperative topical antibiotics and lash trimming in cataract surgery. Ophthalmic Surg. 1977;8(5):44-8.
20. Rodrigues EB, Meyer CH, Grumann A Jr, Shiroma H, Aguni JS, Farah ME. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am J Ophthalmol. 2007;143(6):1035-7.
21. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136(5):791-6.
22. Doft BH, Wisniewski SR, Kelsey SF, Groer-Fitzgerald S; Endophthalmitis Vitrectomy Study Group. Diabetes and postcataract extraction endophthalmitis. Curr Opin Ophthalmol. 2002;13(3):147-51.
23. Song A, Scott IU, Flynn HW Jr, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109(5):985-91.
24. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43(3):193-224. Review.
25. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87(1):24-7.
26. Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J, et al. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105(8):1404-10.
27. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology. 2004;111(11):2044-9.
28. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, Pe'er J. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002; 109(9):1709-16.
29. Korobelnik JF, Cochereau I, Cohen SY, Coscas G, Creuzot-Garcher C, Devin F, et al. [How to perform intravitreal injections]. J Fr Ophtalmol. 2006;29(1): 82-6. French.
30. Pulido JS, Zobitz ME, An KN. Scleral penetration force requirements for commonly used intravitreal needles. Eye. 2007;21(9):1210-1.
31. Pulido JS, Pulido CM, Bakri SJ, McCannel CA, Cameron JD. The use of 31-gauge needles and syringes for intraocular injections. Eye. 2007;21(6): 829-30.